W. Schroeder

Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens

Andreas du Bois, B. Weber, Justine Rochon et al. · Journal of Clinical Oncology · 2006 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes

Stefan Kommoss, Boris Winterhoff, Ann L. Oberg et al. · Clinical Cancer Research · 2017 · 146 citations

Medicine, Oncology, Pharmacology +15

Surgery for Recurrent Ovarian Cancer: Role of Peritoneal Carcinomatosis: Exploratory Analysis of the DESKTOP I Trial About Risk Factors, Surgical Implications, and Prognostic Value of Peritoneal Carcinomatosis

P Harter, Maik Hahmann, Hans-Joachim Lueck et al. · Annals of Surgical Oncology · 2009 · 136 citations

Medicine, Oncology, Surgery +17

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

Jalid Sehouli, Dirk Stengel, Philipp Harter et al. · Journal of Clinical Oncology · 2010 · 103 citations · Full text

Medicine, Oncology, Pharmacology +17

Collagenous colitis: jejunal and colorectal pathology.

Jo Armes, D. C. Gee, Finlay Macrae et al. · Journal of Clinical Pathology · 1992 · 96 citations · Full text

Medicine, Immunology, Pathology +17